Dr Saan Voss is a UKRI Knowledge Transfer Partner between the University of Cambridge (Department of Chemistry) and Bicycle Therapeutics.

Saan received his undergraduate training in pharmaceutical science at the Freie Universität Berlin, before relocating to the Australian National University as fully funded PhD candidate. He earned his PhD in Chemistry for his pioneering work on a novel class of constrained peptides - called 'Bismuth Bicycles' - Angewandte Chemie 2022 & 2024 (media coverage by C&EN magazine 2022). Saan then joined a cross-sector collaboration between the University of Cambridge and Bicycle Therapeutics as UKRI Knowledge Transfer Partner after having secured his first research grant (valued at £330k) before finishing up his PhD program. Today, Saan is driving  the development of next-generation therapeutics by applying his broad expertise ranging from medicinal chemistry over chemical biology to cell biology. He is part of an interdisciplinary research team that works across academia and industry aiming to develop creative solutions to global health challenges. Saan is interested in developing concept designs by reimagining molecular architectures to develop the therapeutics of the future and has a growing interest in synthetic biology.

Saan has secured over £500k in funding so far and has been recognised with a number of prizes from international societies including the Royal Australian Chemical Institute and the Italian Peptide Society (1st Luis Moroder Award).